Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Toffoli

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Mechanism of multidrug resistance in human tumour cell lines and complete reversion of cellular resistanceM Boiocchi, G Toffoli
Tumori|October 30, 1999
[Prognostic significance of folate binding protein in ovarian neoplasms]G Toffoli, S Tumolo
The Pharmacogenomics Journal|June 28, 2006
Clinical implications of genetic polymorphisms on stomach cancer drug therapyG Toffoli, E Cecchin
Journal of Chemotherapy (Florence, Italy)|February 4, 2005
Uridine diphosphoglucuronosyl transferase and methylenetetrahydrofolate reductase polymorphisms as genomic predictors of toxicity and response to irinotecan-, antifolate- and fluoropyrimidine-based chemotherapyG Toffoli, E Cecchin
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|June 1, 1996
[The DNA ploidy in squamous cell carcinomas of the head and neck with particular reference to prognosis]M Boiocchi, G Toffoli, L Barzan
Journal of Chemotherapy (Florence, Italy)|May 10, 2008
UGT1A1*28 and other UGT1A polymorphisms as determinants of irinotecan toxicityP Biason, S Masier, G Toffoli
Tumori|February 29, 1988
Changes in chemosensitivity of K 562 leukemia cells after induction of erythroid differentiation by heminG Toffoli, A Lorico, M Boiocchi
British Journal of Cancer|January 1, 1995
Pharmacokinetics of doxorubicin co-administered with high-dose verapamilM Gigante, G Toffoli, M Boiocchi
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2000
MTHFR gene polymorphism and severe toxicity during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil (CMF)G Toffoli, A Veronesi, M Boiocchi, et al.
Journal of Chemotherapy (Florence, Italy)|July 1, 1989
Chemosensitivity of drug-sensitive and drug-resistant P388 leukemia cell lines after hyperthermic treatmentG Toffoli, C Bevilacqua, A Franceschin, et al.
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Mechanism of multidrug resistance in human tumour cell lines and complete reversion of cellular resistanceM Boiocchi, G Toffoli
Tumori|October 30, 1999
[Prognostic significance of folate binding protein in ovarian neoplasms]G Toffoli, S Tumolo
The Pharmacogenomics Journal|June 28, 2006
Clinical implications of genetic polymorphisms on stomach cancer drug therapyG Toffoli, E Cecchin
Journal of Chemotherapy (Florence, Italy)|February 4, 2005
Uridine diphosphoglucuronosyl transferase and methylenetetrahydrofolate reductase polymorphisms as genomic predictors of toxicity and response to irinotecan-, antifolate- and fluoropyrimidine-based chemotherapyG Toffoli, E Cecchin
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|June 1, 1996
[The DNA ploidy in squamous cell carcinomas of the head and neck with particular reference to prognosis]M Boiocchi, G Toffoli, L Barzan
Journal of Chemotherapy (Florence, Italy)|May 10, 2008
UGT1A1*28 and other UGT1A polymorphisms as determinants of irinotecan toxicityP Biason, S Masier, G Toffoli
Tumori|February 29, 1988
Changes in chemosensitivity of K 562 leukemia cells after induction of erythroid differentiation by heminG Toffoli, A Lorico, M Boiocchi
British Journal of Cancer|January 1, 1995
Pharmacokinetics of doxorubicin co-administered with high-dose verapamilM Gigante, G Toffoli, M Boiocchi
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2000
MTHFR gene polymorphism and severe toxicity during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil (CMF)G Toffoli, A Veronesi, M Boiocchi, et al.
Journal of Chemotherapy (Florence, Italy)|July 1, 1989
Chemosensitivity of drug-sensitive and drug-resistant P388 leukemia cell lines after hyperthermic treatmentG Toffoli, C Bevilacqua, A Franceschin, et al.
Pageof 9